Scientific Review
New drugs—how much are they worth: the Italian experience
Page: 17-25
Abstract:The financing and delivery of health care in Italy, including current schemes to limit the growth in pharmaceutical expenditure, are discussed. Of particular focus is the Onco-AIFA (Agenzia Italiana del… Read More »
Saving money in the European healthcare systems with biosimilars
Abstract: Introduction:The use of biotechnological manufactured drugs, or biologicals, has increased massively over the past few years. Used especially in the treatment of cancer and other severe diseases, biologicals incur… Read More »
Treatment of early breast cancer: an overview
Abstract:In the western world, adjuvant systemic therapy together with widespread use of screening has led to a consistent decrease in breast cancer mortality since the nineties. This review article summarises… Read More »
Stability of Hospira filgrastim following changes to thermal and photic storage conditions
Study objectives: Protein-based medicines have specific storage requirements to ensure chemical stability and purity, but exposure to different environmental conditions can occur in normal use. The effect of extended unrefrigerated… Read More »
Food interactions and oral anticancer therapy
Abstract:Oral delivery for anticancer drugs is an attractive option, especially for palliative treatment. As this approach becomes more widely used, however, it is imperative to consider interactions that do not… Read More »
Treatment of metastatic breast cancer: an overview
Page: 15-18
Abstract:Important progress has been achieved in the field of metastatic breast cancer (MBC) in the last decade. The integration of targeted agents either with endocrine or chemotherapy currently represents the… Read More »
